Collatek® II Collagen Gel is a Kollagen™ product that gives a wound both biological and physical qualities. Collatek® Gel is collagen in the form of a viscous gel. Collatek® is a sterile collagen gel that promotes wound healing by donating moisture to the wound, without causing maceration. Collatek® II Collagen Gel is to be applied… Continue reading Advanced Wound Care Product Collatek® II Collagen Gel
Venous leg ulcers (VLUs) are caused by blood leaking from veins into the skin, causing the skin to break down or produce an ulcer a hole in the skin forms when blood does not flow through the veins as it should. Both men and women are affected by vascular disease. VLUs are more likely among… Continue reading Medifil® II Collagen Particles, Skin Temp® II Collagen Sheets, and Collatek® Gel for Venous Leg Ulcers (VLUs)
Medifil® II Collagen Particles is a Kollagen™ product that gives a wound both biological and physical qualities. The particles have a large surface area, allowing them to effectively penetrate the wound surface and release the maximum quantity of collagen. Medifil® II is a non-hydrolyzed type 1 bovine native collagen that is 100% non-hydrolyzed. This technology approach… Continue reading Advanced Wound Care Product Medifil® II Collagen Particles
Chronic wounds are a constant source of frustration for individuals and health care providers all around the world. Lower extremity wound chronicity affects an amazing 4.5 million persons in the United States, whereas all sorts of chronic wounds afflict an estimated 1% of the Western population. The wound healing cascade does not always follow an… Continue reading Wound Chronicity: Collagen Promotes Reepithelialization
SkinTemp® II is Kollagen™ product that gives a wound both biological and physical qualities. SkinTemp® II is Kollagen™ in sheet form. The dressings are porous collagen membranes that are designed to be permeable and breathable, with fluid control similar to skin. They are flexible, pliable, elastic, and durable for ease of application. SkinTemp® II is… Continue reading Advanced Wound Care Product Skin Temp® II Collagen Sheets
Why Are Medifil II Collagen Particles Different? Although collagen particles are not new to the market, they have recently become one of the most popular advanced wound care products, particularly among surgeons and podiatric physicians. Collagen particles can be incredibly useful as more physicians and wound care professionals explore more rapid and cost-efficient ways to… Continue reading The Medifil II Collagen Particles Difference
When ordering collagen wound dressings or other wound care/surgical dressings, it’s critical to have documentation to back up the medical necessity of the items being billed to the Centers for Medicare and Medicaid Services (CMS). Here are some pointers to make sure your documentation follows CMS’s current criteria. Criteria for Documentation in Support of Medical… Continue reading Billing and Reimbursement for Collagen Wound Dressings
Advanced wound care dressings have a significant impact on the total cost of care. This is essential since chronic wounds affect roughly 6.5 million individuals and cost up to $25 billion per year to treat. Wound dressing formulations are frequently classified as medical devices rather than drugs, depending on the plan design.Several factors are driving… Continue reading How Purchasing Directly From The Manufacturer Can Impact Cost-Effectiveness
Mrs. Vann is responsible for branding, design, and public outreach efforts for the company. Mrs. Vann has over five years of experience in the creative design arena. She has spearheaded multiple marketing campaigns, both domestic and international. She also has experience producing several television and live-stage programs. She has a Bachelor’s Degree in Film and Video Studies from George Mason University.
Mr. Patel is the Vice President of Operations for Human BioSciences. As such, he is responsible for strategy development for optimal growth, organizing multiple teams and implementing optimal product delivery for the growth of HBS. He has served multiple positions within HBS since 2001, including Operations Manager. With an MBA in Pharmaceutical Healthcare and a Bachelor’s in Pharmaceuticals, Mr. Patel brings deep technical knowledge in collagen product production with a rich history in managing teams.
As the President of Human BioSciences, Dr. Rohan K Jain is responsible for the company’s overall operations, with a focus on research and development. Dr. Jain has supervised and conducted extensive research in the collagen, biomaterials, and protein space, resulting in the release of numerous new products to the market. Prior to his role at HBS, Dr. Jain was a capital markets attorney at Shearman & Sterling LLP. He received his Doctorate in Law and his MBA from New York University; his Bachelor’s degrees in Biomedical Engineering and Materials Science and his Master’s in Engineering Management from Johns Hopkins University. He is a member of the New York and Maryland bars.
Cheryl Carver, LPN, WCC, CWCA, CWCP, DAPWCA, FACCWS is responsible for clinical education and training initiatives for customer accounts. Ms. Carver has amassed a wealth of clinical knowledge and industry experience in her more than 20 years as a board-certified wound care nurse. She has authored over 200 published white papers, ebooks, blogs, and articles for WoundSource and freelance.
Dr. Goebel is responsible for the company’s physical infrastructure and global expansion efforts through partnerships. Prior to joining HBS, Dr. Goebel was Managing Director at the Graf Matuschka Group in Munich, Germany, where he was actively involved in restructuring and privatization in East Germany and Eastern Europe. He was also a member of the American group of the EBRD European Bank for Reconstruction and Development in the privatization of the Russian economy and military complex. He has over forty years’ experience in many different industries including medical devices, pharmacy, and others. Dr. Goebel earned his Doctorate and Postdoctoral degrees in Economics in East Berlin.
Mr. Kumar is responsible for the company’s overall accounting and finance activities with a focus on internal control and taxation.
Mr. Kumar has over 25 years of public and corporate accounting experience. He is a Certified Public Accountant, licensed in the State of Virginia, Maryland, and Washington D.C., and an Enrolled Agent authorized to practice before the Internal Revenue Service. Mr. Kumar is also a Chartered Accountant and fellow member of the Institute of Chartered Accountants of India. Mr. Kumar received his Master’s degree in Commerce from Himalayan University in India.
Mr. Slovick is responsible for all regulatory and quality affairs in the company. Mr. Slovick has worked in regulatory, quality, and clinical services within the medical device and diagnostics industry for nearly 40 years. He founded Methodize Inc., to offer strategic support for approval of medical devices and in vitro diagnostics products. Mr. Slovick has a Bachelor’s degree in Management Information Systems.
Mr. Agarwal is responsible for Corporate Business Development, Sales, and Product Development, both locally and internationally for the company. Mr. Agarwal has over six years of corporate sales and business development experience. He completed his Master of Science in Engineering Management degree from Johns Hopkins University with a technical concentration in Mechanical Engineering. In the past, he has also worked as a fundraising volunteer for three years and thus gained insights in community fundraising and business development. Additionally, he has interned at a manufacturing firm and understood various intricacies involved in manufacturing ranging from the floor level to the supply chain. He has published a paper on Omni Channel Supply Chain and is a certified Lean Six Sigma associate. He has also interned as a business development consultant to a startup for market research and pricing strategies in Israel. Equipped with a combination of management and technical background acquired from his diverse experiences and education, he is perfectly suited to lead the business development efforts for Human BioSciences.
